Commentary on Mason et al.

Research output: Contribution to journalComment/debate

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)368-369
Number of pages2
JournalClinical Trials
Volume14
Issue number4
DOIs
StatePublished - Aug 1 2017

ASJC Scopus subject areas

  • Pharmacology

Cite this

Commentary on Mason et al. / Heitjan, Daniel F.

In: Clinical Trials, Vol. 14, No. 4, 01.08.2017, p. 368-369.

Research output: Contribution to journalComment/debate

Heitjan, Daniel F. / Commentary on Mason et al. In: Clinical Trials. 2017 ; Vol. 14, No. 4. pp. 368-369.
@article{1e4e22bdb5bb40b8bbfd3f9bc860ebac,
title = "Commentary on Mason et al.",
author = "Heitjan, {Daniel F.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1177/1740774517711443",
language = "English (US)",
volume = "14",
pages = "368--369",
journal = "Clinical Trials",
issn = "1740-7745",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Commentary on Mason et al.

AU - Heitjan, Daniel F.

PY - 2017/8/1

Y1 - 2017/8/1

UR - http://www.scopus.com/inward/record.url?scp=85026450678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026450678&partnerID=8YFLogxK

U2 - 10.1177/1740774517711443

DO - 10.1177/1740774517711443

M3 - Comment/debate

C2 - 28532162

AN - SCOPUS:85026450678

VL - 14

SP - 368

EP - 369

JO - Clinical Trials

JF - Clinical Trials

SN - 1740-7745

IS - 4

ER -